ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-42 Cr | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr | ₹-15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-42 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-16 Cr |
| Mar2021 | ₹-15 Cr |
How is Deferred Tax Assets / Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-42 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-16 Cr | Negative | |
| Mar2021 | ₹-15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,016.5 Cr | -0.2% | -2.4% | -19.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -0.2% |
-2.4% |
-19.1% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses